Jul
26
2017
Health Canada Approves ADCETRIS® (Brentuximab Vedotin) for the Post-ASCT Consolidation Treatment of Patients with Hodgkin Lymphoma
Jul
07
2017
Treatment with a new targeted therapy, duvelisib, has shown sustained efficacy and sa
Jul
07
2017
Recently, a group of Manitoba CLL experts formed the Integrated Multidisciplinary CLL Research Cluster – a collaborative that combines the knowledge and expertise of oncolog
Jun
05
2017
If you have or had Hodgkin lymphoma or you are or were a caregiver of a patient with Hodgkin lymphoma, you can help by completing our surveys.
May
29
2017
Feb
13
2017
New targeted treatment now available for Canadians living with the most common form of slow-growing, non-Hodgkin's lymphoma
Jan
24
2017
A small study suggests that pembrolizumab may provid
Jan
13
2017
The BCCA Provincial Systemic Therapy Program approves Bendamustine With Rituximab for Previously Untreated CLL or SLL
Jan
05
2017
Promising results [10.1016/j.ymthe.2016.10.020] from the phase 1 portion of a multi-center phase
